ArticleDiscover nano2026
In-vitro analysis, metabolic profiling and in-silico molecular docking analysis shows antidiabetic potential of phytofabricated cerium oxide nanoparticles against diabetes related receptors.
Article in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plants play a vital role in sustaining life on Earth, offering essential resources such as food, energy, shelter, and serving as a key source for drug development. Chemical pharmaceutics come with a range of disadvantages, including potential side effects, high costs, and limited availability in certain regions. There is an urgent need for sustainable, cost-effective, plant-based drug development approaches to ensure accessibility, minimize environmental impact, and promote long-term healthcare solutions. Nano biotechnology, focusing on nanoscale materials, has vast applications in drug delivery and therapy. This study synthesized Cerium oxide nanoparticles (CeO
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.